Anti-Cardiovascular Drug Evacetrapib Intermediates 7,9-dimethyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one CAS 886367-24-4

Basic Info

Model No.: 886367-24-4

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

Evacetrapib Intermediates 7,9-dimethyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one CAS 886367-24-4 is main product in our company, which is customized according to customers requirements. The HPLC of the Evacetrapib ( LY2484595) Intermediates 7,9-dimethyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one CAS NO 886367-24-4 is more than 99%, and its well-known for secure formulation and fast action. We can offer various of packaging to meet customers requirement, and transport the Evacetrapib Intermediates 886367-24-4 to appointed destination.

Thera. Category: Anti-Cardiovascula

Cas No.: 886367-24-4

Synonym: 7,9-DIMETHYL-1,2,3,4-TETRAHYDRO-BENZO[B]AZEPIN-5-ONE;7,9-dimethyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one

Molecular Formula: C12H15NO

Molecular Weight: 189.2536

Assay: ≥98.%

Appearance: White Crystalline solid

Storage: normal

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Usage:

Evacetrapib 886367-24-4, as know as LY2484595 Which is a selective inhibitor of cholesteryl ester transfer protein (CETP), was an important near-term opportunity for the Indianapolis-based pharma as one of just seven assets in phase III studies. The candidate also was among the remaining late-stage contenders in a drug class viewed by some as the potential successor to proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, which recently began to hit the market.